CELLECT BIOTECHNOLOGY LTD's ticker is APOP and the CUSIP is 15116C102. A total of 4 filers reported holding CELLECT BIOTECHNOLOGY LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $124,000 | -42.1% | 243,563 | +15.0% | 0.16% | +51.5% |
| Q1 2019 | $214,000 | +154.8% | 211,854 | +429.2% | 0.10% | +472.2% |
| Q4 2018 | $84,000 | -79.6% | 40,032 | -53.7% | 0.02% | -66.0% |
| Q3 2018 | $412,000 | -48.4% | 86,517 | -22.4% | 0.05% | -56.9% |
| Q2 2018 | $798,000 | -74.4% | 111,540 | -77.1% | 0.12% | -33.9% |
| Q1 2018 | $3,114,000 | +1659.3% | 487,960 | +750.9% | 0.19% | +1760.0% |
| Q4 2016 | $177,000 | -33.0% | 57,348 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $264,000 | – | 57,348 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 57,348 | $264,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 400 | $2,000 | 0.00% |
| JANE STREET GROUP, LLC | 16,515 | $76,000 | 0.00% |
| UBS Group AG | 600 | $3,000 | 0.00% |